Droplet Biosciences

Droplet Biosciences was founded in 2021, is headquartered in Cambridge, United States, lists 11–50 employees, and has $8.0M in recorded funding across 1 round.

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M SeedMar 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Droplet Biosciences has pioneered a platform to harvest and profile patient lymph through the routine collection of surgical drain fluid, providing a novel window into the tumor microenvironment following cancer surgery. The lymphatic system has long been recognized as central to cancer metastasis, yet lymph fluid has never before been feasible to access routinely for research or diagnosis. By concentrating lymphatic fluid collected immediately after surgery, Droplet's liquid biopsy platform offers superior proximity to the tumor site for assessing recurrence risk, drawing on the team's expertise in oncology, surgery, genomics, diagnostics, biology, and bioinformatics.

Summary

Droplet Biosciences is a Biotech company based in Cambridge, United States, founded in 2021. It lists 11–50 employees. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Mar 2023. Investors include The Engine and North South Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2023
$8.0M

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Droplet Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/droplet-biosciences"><img src="https://indexed.vc/api/badge/company/droplet-biosciences" alt="Droplet Biosciences on Indexed.vc" width="260" height="76" /></a>